These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24065152)

  • 1. Start of insulin therapy in patients with type 2 diabetes mellitus promotes the influx of macrophages into subcutaneous adipose tissue.
    Jansen HJ; Stienstra R; van Diepen JA; Hijmans A; van der Laak JA; Vervoort GM; Tack CJ
    Diabetologia; 2013 Dec; 56(12):2573-81. PubMed ID: 24065152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans.
    Tam CS; Viardot A; Clément K; Tordjman J; Tonks K; Greenfield JR; Campbell LV; Samocha-Bonet D; Heilbronn LK
    Diabetes; 2010 Sep; 59(9):2164-70. PubMed ID: 20547978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic insulin therapy reduces adipose tissue macrophage content in LDL-receptor-deficient mice.
    Yoon J; Subramanian S; Ding Y; Wang S; Goodspeed L; Sullivan B; Kim J; O'Brien KD; Chait A
    Diabetologia; 2011 May; 54(5):1252-60. PubMed ID: 21327868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes.
    Acosta JR; Douagi I; Andersson DP; Bäckdahl J; Rydén M; Arner P; Laurencikiene J
    Diabetologia; 2016 Mar; 59(3):560-70. PubMed ID: 26607638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver fat content is linked to inflammatory changes in subcutaneous adipose tissue in type 2 diabetes patients.
    Jansen HJ; Vervoort GM; van der Graaf M; Stienstra R; Tack CJ
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):661-6. PubMed ID: 23167778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of insulin therapy on weight gain and fat distribution in the HF/HS-STZ rat model of type 2 diabetes.
    Skovsø S; Damgaard J; Fels JJ; Olsen GS; Wolf XA; Rolin B; Holst JJ
    Int J Obes (Lond); 2015 Oct; 39(10):1531-8. PubMed ID: 26121961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
    Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G
    Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pronounced weight gain in insulin-treated patients with type 2 diabetes mellitus is associated with an unfavourable cardiometabolic risk profile.
    Jansen HJ; Vervoort G; van der Graaf M; Tack CJ
    Neth J Med; 2010 Nov; 68(11):359-66. PubMed ID: 21116029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.
    Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Sandhu S; Green K; Makdissi A; Hejna J; Chaudhuri A; Punyanitya M; Dandona P
    Diabetes Care; 2016 Jan; 39(1):82-91. PubMed ID: 26622051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Glucose control-related' and 'non-glucose control-related' effects of insulin on weight gain in newly insulin-treated type 2 diabetic patients.
    Sallé A; Ryan M; Guilloteau G; Bouhanick B; Berrut G; Ritz P
    Br J Nutr; 2005 Dec; 94(6):931-7. PubMed ID: 16351770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low proliferative potential of adipose-derived stromal cells associates with hypertrophy and inflammation in subcutaneous and omental adipose tissue of patients with type 2 diabetes mellitus.
    Stafeev I; Podkuychenko N; Michurina S; Sklyanik I; Panevina A; Shestakova E; Yah'yaev K; Fedenko V; Ratner E; Vorotnikov A; Menshikov M; Yashkov Y; Parfyonova Y; Shestakova M
    J Diabetes Complications; 2019 Feb; 33(2):148-159. PubMed ID: 30482492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes.
    van Diepen JA; Robben JH; Hooiveld GJ; Carmone C; Alsady M; Boutens L; Bekkenkamp-Grovenstein M; Hijmans A; Engelke UFH; Wevers RA; Netea MG; Tack CJ; Stienstra R; Deen PMT
    Diabetologia; 2017 Jul; 60(7):1304-1313. PubMed ID: 28382382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of equine body weight gain on inflammatory cytokine expressions of adipose tissue in response to endotoxin challenge.
    Blaue D; Schedlbauer C; Starzonek J; Gittel C; Brehm W; Blüher M; Pfeffer M; Vervuert I
    Acta Vet Scand; 2020 Apr; 62(1):17. PubMed ID: 32321549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
    Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
    Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study.
    Tripathy D; Daniele G; Fiorentino TV; Perez-Cadena Z; Chavez-Velasquez A; Kamath S; Fanti P; Jenkinson C; Andreozzi F; Federici M; Gastaldelli A; Defronzo RA; Folli F
    Diabetologia; 2013 Oct; 56(10):2153-63. PubMed ID: 23811853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Licochalcone F alleviates glucose tolerance and chronic inflammation in diet-induced obese mice through Akt and p38 MAPK.
    Bak EJ; Choi KC; Jang S; Woo GH; Yoon HG; Na Y; Yoo YJ; Lee Y; Jeong Y; Cha JH
    Clin Nutr; 2016 Apr; 35(2):414-421. PubMed ID: 25823386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a reference four-component model to define the effects of insulin treatment on body composition in type 2 diabetes: the 'Darwin study'.
    Packianathan IC; Fuller NJ; Peterson DB; Wright A; Coward WA; Finer N
    Diabetologia; 2005 Feb; 48(2):222-9. PubMed ID: 15688205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bed-time insulin versus pioglitazone on abdominal fat accumulation, inflammation and gene expression in adipose tissue in patients with type 2 diabetes.
    Hartemann-Heurtier A; Halbron M; Golmard JL; Jacqueminet S; Bastard JP; Rouault C; Ayed A; Pieroni L; Clément K; Grimaldi A
    Diabetes Res Clin Pract; 2009 Oct; 86(1):37-43. PubMed ID: 19683825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue and body composition in women six years after gestational diabetes: factors associated with development of type 2 diabetes.
    Svensson H; Wetterling L; Andersson-Hall U; Jennische E; Edén S; Holmäng A; Lönn M
    Adipocyte; 2018; 7(4):229-237. PubMed ID: 30246599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.